Detalles de la búsqueda
1.
Biomarker and pharmacodynamic activity of the transforming growth factor-beta (TGFß) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors.
Clin Transl Sci
; 17(2): e13736, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38362837
Resultados
1 -
1
de 1
1
Próxima >
>>